Administration of defined microbiota is protective in a murine Salmonella infection model

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Martz, Sarah Lynn E ^a   Mcdonald, Julie A K ^a   Sun, Jun ^b   Zhang, Yong Guo ^b   Gloor, Gregory B ^c   Noordhof, Curtis ^a   He, Shu Mei ^a   Gerbaba, Teklu K ^a   Blennerhassett, Michael ^a   Hurlbut, David J ^a   Allen Vercoe, Emma ^d   Claud, Erika C ^e   Petrof, Elaine O ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF GUELPH   (Canada)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 1; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUCIN; PROTEIN ZO1; RNA 16S; TJP1 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ANIMAL; BACTERIUM; BLOOD; BODY WEIGHT; C57BL MOUSE; CECUM; CHEMISTRY; COLITIS; DISEASE MODEL; DNA SEQUENCE; FECES; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; INTESTINE; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MICROFLORA; MOUSE; NEUTROPHIL; PATHOGENICITY; PATHOLOGY; PHYLOGENY; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA INFECTIONS, ANIMAL; SPLEEN; TIGHT JUNCTION;

ANIMALS; BACTERIA; BODY WEIGHT; CECUM; CLAUDIN-1; COLITIS; CYTOKINES; DISEASE MODELS, ANIMAL; FECES; HUMANS; INTESTINAL MUCOSA; INTESTINES; MICE; MICE, INBRED C57BL; MICROBIOTA; MUCINS; NEUTROPHILS; NF-KAPPA B; PHYLOGENY; RNA, RIBOSOMAL, 16S; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SEQUENCE ANALYSIS, DNA; SPLEEN; TIGHT JUNCTIONS; TUMOR NECROSIS FACTOR-ALPHA; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84946229508     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16094     Document Type: Article

References (56)

1. Mueller, C. & Macpherson, A. J. Layers of mutualism with commensal bacteria protect us from intestinal inflammation. Gut 55, 276-284 (2006
2. Bäckhed, F. et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 12, 611-622 (2012
3. Sekirov, I., Russell, S. L., Antunes, L. C. M. & Finlay, B. B. Gut microbiota in health and disease. Physiol. Rev. 90, 859-904 (2010
4. Endt, K. et al. The Microbiota Mediates Pathogen Clearance from the Gut Lumen after Non-Typhoidal Salmonella Diarrhea. PLoS Pathog 6, e1001097 (2010
5. Chung, H. et al. Gut Immune Maturation Depends on Colonization with a Host-Specific Microbiota. Cell 149, 1578-1593 (2012
6. Rajili?-Stojanovi?, M. et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141, 1792-1801 (2011
7. Lee, K. N. & Lee, O. Y. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World J. Gastroenterol. WJG 20, 8886-8897 (2014
8. Hedin, C. R. et al. Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn?s disease and their unaffected siblings. Gut 63, 1578-1586 (2014
9. Willing, B. P. et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139, 1844-1854.e1 (2010
10. Kootte, R. S. et al. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes. Metab. 14, 112-120 (2012
11. Ley, R. E. Obesity and the human microbiome. Curr. Opin. Gastroenterol. 26, 5-11 (2010
12. Brown, C. T. et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PloS One 6, e25792 (2011
13. Larsen, N. et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PloS One 5, e9085 (2010
14. Upadhyaya, S. & Banerjee, G. Type 2 diabetes and gut microbiome: at the intersection of known and unknown. Gut Microbes 6, 85-92 (2015
15. Sekirov, I. et al. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect. Immun. 76, 4726-4736 (2008
16. Ubeda, C. et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J. Clin. Invest. 120, 4332-4341 (2010
17. Majowicz, S. E. et al., International Collaboration on Enteric Disease ?Burden of Illness? Studies. The global burden of nontyphoidal Salmonella gastroenteritis. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 50, 882-889 (2010
18. Pavia, A. T. et al. Epidemiologic evidence that prior antimicrobial exposure decreases resistance to infection by antimicrobialsensitive Salmonella. J. Infect. Dis. 161, 255-260 (1990
19. Grisaru-Soen, G., Wysoki, M. G. & Keller, N. Risk factors for development of nontyphoid Salmonella bacteremia. Clin. Pediatr. (Phila.) 43, 825-829 (2004
20. Nisbet, D. J. et al. Effect of a defined continuous-flow derived bacterial culture and dietary lactose on Salmonella typhimurium colonization in broiler chickens. Avian Dis. 37, 1017-1025 (1993
21. Barthel, M. et al. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 71, 2839-2858 (2003
22. Thiennimitr, P., Winter, S. E. & Bäumler, A. J. Salmonella, the host and its microbiota. Curr. Opin. Microbiol. 15, 108-114 (2012
23. Petrof, E. O. et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ?RePOOPulating? the gut. Microbiome 1, 3 (2013
24. Kamada, N., Chen, G. Y., Inohara, N. & Núnez, G. Control of pathogens and pathobionts by the gut microbiota. Nat. Immunol. 14, 685-690 (2013
25. Valdez, Y., Ferreira, R. B. R. & Finlay, B. B. Molecular mechanisms of Salmonella virulence and host resistance. Curr. Top. Microbiol. Immunol. 337, 93-127 (2009
26. Antunes, L. C. M. et al. Antivirulence activity of the human gut metabolome. mBio 5, e01183-01114 (2014
27. Lara-Tejero, M. et al. Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis. J. Exp. Med. 203, 1407-1412 (2006
28. Fournier, B. M. & Parkos, C. A. The role of neutrophils during intestinal inflammation. Mucosal Immunol. 5, 354-366 (2012
29. Arnold, J. W. et al. Tumor necrosis factor-Alpha mediates the early pathology in Salmonella infection of the gastrointestinal tract. Microb. Pathog. 14, 217-227 (1993
30. Yang, K. K. et al. Neutrophil influx in response to a peritoneal infection with Salmonella is delayed in lipopolysaccharide-binding protein or CD14-deficient mice. J. Immunol. Baltim. Md 1950 169, 4475-4480 (2002
31. Cheminay, C., Chakravortty, D. & Hensel, M. Role of neutrophils in murine salmonellosis. Infect. Immun. 72, 468-477 (2004
32. Strauss, R. R., Paul, B. B., Jacobs, A. A. & Sbarra, A. J. Mouse splenic peroxidase and its role in bactericidal activity. Infect. Immun. 5, 120-126 (1972
33. Zarepour, M. et al. The mucin Muc2 limits pathogen burdens and epithelial barrier dysfunction during Salmonella enterica serovar Typhimurium colitis. Infect. Immun. 81, 3672-3683 (2013
34. Bergstrom, K. S. B. et al. Muc2 Protects against Lethal Infectious Colitis by Disassociating Pathogenic and Commensal Bacteria from the Colonic Mucosa. PLoS Pathog 6, e1000902 (2010
35. Liao, A. P. et al. Salmonella type III effector AvrA stabilizes cell tight junctions to inhibit inflammation in intestinal epithelial cells. PloS One 3, e2369 (2008
36. Köhler, H. et al. Salmonella enterica serovar Typhimurium regulates intercellular junction proteins and facilitates transepithelial neutrophil and bacterial passage. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G178-187 (2007
37. Thiennimitr, P. et al. Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota. Proc. Natl. Acad. Sci. USA 108, 17480-17485 (2011
38. Winter, S. E. et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467, 426-429 (2010
39. Denker, B. M. & Nigam, S. K. Molecular structure and assembly of the tight junction. Am. J. Physiol. 274, F1-9 (1998
40. Boyle, E. C., Brown, N. F. & Finlay, B. B. Salmonella enterica serovar Typhimurium effectors SopB, SopE, SopE2 and SipA disrupt tight junction structure and function. Cell. Microbiol. 8, 1946-1957 (2006
41. Tlaskalová-Hogenová, H. et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell. Mol. Immunol. 8, 110-120 (2011
42. Kim, Y. S. & Ho, S. B. Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr. Gastroenterol. Rep. 12, 319-330 (2010
43. Ginzberg, H. H. et al. Neutrophil-mediated epithelial injury during transmigration: role of elastase. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G705-717 (2001
44. Szabady, R. L. & McCormick, B. A. Control of neutrophil inflammation at mucosal surfaces by secreted epithelial products. Front. Immunol. 4, 220 (2013
45. Symonds, E. L. et al. Bifidobacterium infantis 35624 protects against salmonella-induced reductions in digestive enzyme activity in mice by attenuation of the host inflammatory response. Clin. Transl. Gastroenterol. 3, e15 (2012
46. Castillo, N. A., Perdigon, G. & de Moreno de LeBlanc, A. Oral administration of a probiotic Lactobacillus modulates cytokine production and TLR expression improving the immune response against Salmonella enterica serovar Typhimurium infection in mice. BMC Microbiol. 11, 177 (2011
47. Lawley, T. D. et al. Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice. PLoS Pathog 8, e1002995 (2012
48. Buffie, C. G. et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517, 205-208 (2015
49. Zhang, Y. et al. Axin1 prevents Salmonella invasiveness and inflammatory response in intestinal epithelial cells. PloS One 7, e34942 (2012
50. Kim, H.-J., Park, S.-H. & Kim, H.-Y. Comparison of Salmonella enterica serovar Typhimurium LT2 and non-LT2 salmonella genomic sequences, and genotyping of salmonellae by using PCR. Appl. Environ. Microbiol. 72, 6142-6151 (2006
51. McClelland, M. et al. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413, 852-856 (2001
52. Johansson, M. E. V. & Hansson, G. C. Preservation of mucus in histological sections, immunostaining of mucins in fixed tissue, and localization of bacteria with FISH. Methods Mol. Biol. Clifton NJ 842, 229-235 (2012
53. Lourenssen, S., Houpt, E. R., Chadee, K. & Blennerhassett, M. G. Entamoeba histolytica Infection and Secreted Proteins Proteolytically Damage Enteric Neurons. Infect. Immun. 78, 5332-5340 (2010
54. Forbes, S. J., Eschmann, M. & Mantis, N. J. Inhibition of Salmonella enterica Serovar Typhimurium Motility and Entry into Epithelial Cells by a Protective Antilipopolysaccharide Monoclonal Immunoglobulin A Antibody. Infect. Immun. 76, 4137-4144 (2008
55. Schmittgen, T. D. & Livak, K. J. Analyzing real-Time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101-1108 (2008
56. Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590-D596 (2013